Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pignon

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Nouvelle Revue Francaise D'Hematologie|July 1, 1994
[Mitoxantrone-aracytine with or without quinine in the treatment of refractory or relapsed acute leukemia]E Solary, F Witz, P Moreau, et al.
Leukemia|August 1, 1995
In vitro study of THP-doxorubicin retention in human leukemic cells using confocal laser microspectrofluorometryB Pignon, H Morjani, J P Vilque, et al.
Cancer Treatment Reports|November 1, 1982
Autologous bone marrow transplantation in acute myeloid leukemia in relapse or in complete remissionP Herve, A Rozenbaum, E Plouvier, et al.
Vox Sanguinis|February 12, 2009
Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular productJ-C Capiod, C Tournois, F Vitry, et al.
British Journal of Haematology|July 1, 1986
Autologous bone marrow transplantation (ABMT) for acute leukaemia in complete remission: a pilot study of 33 casesJ Y Cahn, P Herve, M Flesch, et al.
Leukemia|January 1, 1992
Autologous bone marrow transplantation vs intensive chemotherapy in first complete remission: interim results of GOELAM study in AMLJ L Harousseau, B Pignon, P Dufour, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Evaluation of the efficacy of prophylactic intravenous antibiotherapy with ceftriaxone in post-chemotherapy agranulocytic patientsB Pignon, L Thiriet, D Aubert, et al.
Cancer|October 20, 1999
Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS GroupN Ifrah, F Witz, J P Jouet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 TrialP Solal-Céligny, E Lepage, N Brousse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodiesC Foussard, P Colombat, H Maisonneuve, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Nouvelle Revue Francaise D'Hematologie|July 1, 1994
[Mitoxantrone-aracytine with or without quinine in the treatment of refractory or relapsed acute leukemia]E Solary, F Witz, P Moreau, et al.
Leukemia|August 1, 1995
In vitro study of THP-doxorubicin retention in human leukemic cells using confocal laser microspectrofluorometryB Pignon, H Morjani, J P Vilque, et al.
Cancer Treatment Reports|November 1, 1982
Autologous bone marrow transplantation in acute myeloid leukemia in relapse or in complete remissionP Herve, A Rozenbaum, E Plouvier, et al.
Vox Sanguinis|February 12, 2009
Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular productJ-C Capiod, C Tournois, F Vitry, et al.
British Journal of Haematology|July 1, 1986
Autologous bone marrow transplantation (ABMT) for acute leukaemia in complete remission: a pilot study of 33 casesJ Y Cahn, P Herve, M Flesch, et al.
Leukemia|January 1, 1992
Autologous bone marrow transplantation vs intensive chemotherapy in first complete remission: interim results of GOELAM study in AMLJ L Harousseau, B Pignon, P Dufour, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Evaluation of the efficacy of prophylactic intravenous antibiotherapy with ceftriaxone in post-chemotherapy agranulocytic patientsB Pignon, L Thiriet, D Aubert, et al.
Cancer|October 20, 1999
Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS GroupN Ifrah, F Witz, J P Jouet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 TrialP Solal-Céligny, E Lepage, N Brousse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodiesC Foussard, P Colombat, H Maisonneuve, et al.
Pageof 6